MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.340
-0.010
-0.74%
After Hours: 1.340 0 -0.01% 19:59 05/22 EDT
OPEN
1.350
PREV CLOSE
1.350
HIGH
1.380
LOW
1.330
VOLUME
3.94M
TURNOVER
--
52 WEEK HIGH
2.725
52 WEEK LOW
0.7300
MARKET CAP
453.62M
P/E (TTM)
-5.7833
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OCGN last week (0511-0515)?
Weekly Report · 5d ago
Ocugen Inc. Stock Slips 4.8%, Underperforms Market
Dow Jones · 05/15 20:35
Ocugen Raises $130 Million Through Convertible Notes Offering
TipRanks · 05/14 22:53
Ocugen Announces Interim Chief Medical Officer Appointment Transition
TipRanks · 05/14 22:43
OCUGEN, INC. ANNOUNCES CLOSING FOR $130.0 MILLION OF 6.75% CONVERTIBLE SENIOR NOTES
Reuters · 05/14 20:30
Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes
Barchart · 05/14 15:30
Ocugen to Participate in Upcoming May Scientific and Investor Conferences
Barchart · 05/13 06:02
Ocugen Maintained at Buy as Analyst Cites Compelling Gene Therapy Data and Keeps $12 Price Target Unchanged
TipRanks · 05/11 13:26
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Novel Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.